INITIATIVES THAT IMPACT PRICING AND REIMBURSEMENT OF ORPHAN (AND ULTRA ORPHAN) DRUGS: REVIEW OF EUROPEAN TRENDS

被引：1
|
作者：
Rousseau, B. [1 ]
Poinas, A. [1 ]
Oliver, L. [1 ]
Collings, H. [1 ]
机构：
[1] Adelphi Values Ltd, Bollington, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1787
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP251
引用
收藏
页码：A695 / A696
页数：2
相关论文
共 50 条
  • [41] Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
    Alain Denis
    Lut Mergaert
    Christel Fostier
    Irina Cleemput
    Frank Hulstaert
    Steven Simoens
    [J]. PharmacoEconomics, 2011, 29 : 883 - 893
  • [42] Reimbursement of orphan drugs in Belgium: what (else) matters?
    Eline Picavet
    David Cassiman
    Steven Simoens
    [J]. Orphanet Journal of Rare Diseases, 9
  • [43] Reimbursement of orphan drugs in Belgium: what (else) matters?
    Picavet, Eline
    Cassiman, David
    Simoens, Steven
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [44] RECOMMENDATIONS AND REIMBURSEMENT STATUS OF ORPHAN DRUGS IN UE COUNTRIES
    Kawalec, P.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [45] INSIGHTS INTO REIMBURSEMENT RATES AND TIMELINES FOR ORPHAN DRUGS IN IRELAND
    Marsh, S. E.
    [J]. VALUE IN HEALTH, 2019, 22 : S726 - S726
  • [46] Analysing criteria for price and reimbursement of orphan drugs in Spain
    Badia, Xavier
    Gil, Alicia
    Luis Poveda-Andres, Jose
    Shepherd, John
    Tort, Marina
    [J]. FARMACIA HOSPITALARIA, 2019, 43 (04) : 121 - 127
  • [47] A REVIEW OF PRICING OF ORPHAN DRUGS FOR LEUKEMIA IN THE UNITED STATES VERSUS ENGLAND
    Smith, C.
    Hyeon, Joo K.
    Briceno, V
    Pompilus, F. A.
    Shukla, V
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A245 - A245
  • [48] A review of international coverage and pricing strategies for personalized medicine and orphan drugs
    Degtiar, Irina
    [J]. HEALTH POLICY, 2017, 121 (12) : 1240 - 1248
  • [49] Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
    Eichler, Hans-Georg
    Kossmeier, Michael
    Zeitlinger, Markus
    Schwarzer-Daum, Brigitte
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] TIME FOR A EUROPEAN ORPHAN DRUGS POLICY
    LEBLOND, D
    [J]. EUROPEAN CHEMICAL NEWS, 1995, 63 (1652): : 17 - 17
12345